imiquimod has been researched along with calcitriol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bowen, AR; Herron, MD; Krueger, GG | 1 |
| Bäumer, W; Dickhaut, J; Japtok, L; Kietzmann, M; Kleuser, B; Mischke, R; Schaper, K | 1 |
| Haddad, E; Hatami, A; Marcoux, D; McCuaig, CC; Piram, M; Powell, J; Saint-Cyr, C | 1 |
| Dou, W; Hu, J; Sun, J; Zhao, Y | 1 |
| Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K | 1 |
| Dainichi, T; Egawa, G; Honda, T; Kabashima, K; Kitoh, A; Kusuba, N; Miyachi, Y; Nakajima, S; Otsuka, A | 1 |
| Aranegui, B; Jiménez-Reyes, J | 1 |
| Asano, Y; Hau, CS; Kadono, T; Kamata, M; Mitsui, A; Sato, S; Shibata, S; Shimizu, T; Sugaya, M; Tada, Y; Takeoka, S; Watanabe, S | 1 |
| Enomoto, Y; Fukuda, H; Hirata, A; Nagasawa, T; Niiyama, S | 1 |
| Chen, L; Cornelius, LA; Demehri, S; Faulkner-Jones, BE; Khalifian, S; Molina, GE; Mull, JL; Ngo, KH; Rosman, IS; Wu, PA | 1 |
| Fukaya, S; Fukuyasu, A; Hau, CS; Hayashi, K; Ishikawa, T; Kamata, M; Ohnishi, T; Shimizu, T; Tada, Y; Takeoka, S; Tanaka, T | 1 |
| Fujimoto, M; Fujisawa, Y; Ichimura, Y; Ishitsuka, Y; Kubota, N; Mizuno, S; Nakamura, Y; Okiyama, N; Saito, A; Takahashi, S; Tanaka, R; Watanabe, R | 1 |
1 review(s) available for imiquimod and calcitriol
| Article | Year |
|---|---|
Morphea in Childhood: An Update.
Topics: Acute-Phase Proteins; Bosentan; Calcitriol; Child; Child, Preschool; Female; Humans; Imiquimod; Immunosuppressive Agents; Incidence; Male; Phototherapy; Prevalence; Prognosis; Quality of Life; Scleroderma, Localized; Vitamin D | 2018 |
1 trial(s) available for imiquimod and calcitriol
| Article | Year |
|---|---|
Seborrheic keratoses: a study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Calcitriol; Cryosurgery; Dermatologic Agents; Drug Administration Schedule; Female; Humans; Imiquimod; Keratosis, Seborrheic; Male; Middle Aged; Nicotinic Acids; Pilot Projects; Retinoids; Treatment Outcome | 2004 |
11 other study(ies) available for imiquimod and calcitriol
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cell Differentiation; Cell Proliferation; Dermatologic Agents; Disease Models, Animal; Female; Fingolimod Hydrochloride; Humans; Imiquimod; Keratinocytes; Local Lymph Node Assay; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, SCID; Propylene Glycols; Psoriasis; Receptors, Lysosphingolipid; Skin; Skin Transplantation; Sphingosine; Sphingosine-1-Phosphate Receptors; Time Factors | 2013 |
Short- and long-term outcome of linear morphoea in children.
Topics: Adolescent; Adrenal Cortex Hormones; Age of Onset; Aminoquinolines; Calcitriol; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Imiquimod; Male; Methotrexate; Ointments; Phototherapy; Retrospective Studies; Scleroderma, Localized; Tacrolimus; Treatment Outcome; Vitamin A; Vitamin E | 2013 |
A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents; Calcitriol; Camptothecin; Clobetasol; Dermatologic Agents; Disease Models, Animal; Humans; Imiquimod; Mice; Mice, Inbred BALB C; Nicotinic Acids; Psoriasis; Topoisomerase I Inhibitors | 2014 |
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays | 2016 |
Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
Topics: Animals; Calcitriol; Disease Models, Animal; Gene Expression Regulation; Humans; Imiquimod; Interleukin-12 Subunit p40; Interleukin-17; Interleukin-23 Subunit p19; Mice; Psoriasis; Th17 Cells | 2018 |
The vitamin D
Topics: Adoptive Transfer; Animals; Betamethasone Valerate; Calcitriol; Dermatologic Agents; Down-Regulation; Female; Humans; Imiquimod; Interleukin-17; Interleukin-23; Mice; Mice, Inbred BALB C; Psoriasis; Skin; T-Lymphocytes, Regulatory; Treatment Outcome | 2018 |
Successful treatment of porocarcinoma with maxacalcitol and imiquimod.
Topics: Aged, 80 and over; Antineoplastic Agents; Calcitriol; Eccrine Porocarcinoma; Female; Humans; Imiquimod; Sweat Gland Neoplasms; Treatment Outcome | 2019 |
Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease.
Topics: Administration, Topical; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Female; Fluorouracil; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Palliative Care; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2019 |
Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
Topics: Administration, Cutaneous; Animals; Betamethasone; Calcitriol; Cytokines; Dermatologic Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Gene Expression Regulation; Glucocorticoids; Humans; Imiquimod; Mice; Ointments; Psoriasis; Skin; Th1 Cells; Th17 Cells | 2020 |
Differential Involvement of Programmed Cell Death Ligands in Skin Immune Responses.
Topics: Animals; Antigen Presentation; B7-H1 Antigen; Calcitriol; Cells, Cultured; Cytokines; Dendritic Cells; Dermatitis, Atopic; Dermatitis, Contact; Dinitrofluorobenzene; Disease Models, Animal; Humans; Imiquimod; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Programmed Cell Death 1 Ligand 2 Protein; Psoriasis; Skin; Th1 Cells; Th17 Cells; Th2 Cells | 2022 |